liver cancer
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
July, 2024
July 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jun
liver cancer
Jul 16, 2024, 20:15 |
Blog
Ghassan Abou-Alfa: The struggle of HCC liver cancer of the different islands and atolls of the Pacific Ocean
Ghassan Abou-Alfa, Associate Attending at Memorial Sloan Kettering Cancer Center, shared a post on X:…
Jul 8, 2024, 18:50 |
Blog
Tumor Board Tuesday on Durva + TACE for HCC
Tumor Board Tuesday published the following post on X: “Did you know that there are…
Jul 2, 2024, 09:01 |
Societies
Key points from ESMOGI24 by Arndt Vogel
ESMO GI 2024 is held in Munich, Germany, and online from June 26-29. Organized by…
Jun 27, 2024, 02:53 |
Blog
Tanja Obradovic: Tempest Therapeutics just announced very good results from ongoing global clinical study with Amezalpat
Tanja Obradovic shared on LinkedIn: . “Are we to expect completely new mechanism of action…
Jun 16, 2024, 15:58 |
Insight
SBRT and liver transplant in previously untreated unresectable hepatocellular carcinoma
Erman Akkus, Medical Oncology Fellow at Ankara University Faculty of Medicine, shared a post on…
Jun 9, 2024, 08:15 |
Cancer Types
Liver Cancer: What patients should know about
Introduction Liver cancer is a serious condition that occurs when abnormal cells in the liver grow uncontrollably. It can be classified into…
Jun 7, 2024, 13:51 |
Blog
Nishwant Swami: Incredibly proud of Joyce Tien for leading our piece on the importance of disaggregation
Nishwant Swami, Internal Medicine Resident Physician at the Hospital of the University of Pennsylvania, shared…
May 21, 2024, 03:45 |
Blog
Susanna Greer: Outsmarting liver cancer with a double whammy
Susanna Greer, Chief Scientific Officer at the V Foundation for Cancer Research, published the following…
May 19, 2024, 10:35 |
Blog
Aisling Barry: Thrilled to now offer liver SBRT for patients with liver cancer at Cork University Hospital
Aisling Barry, Professor and Chair of Radiation Oncology at University College Cork, posted on LinkedIn:…
May 8, 2024, 02:47 |
Blog
Cecilia Monge: Very proud of Gabriela Arroyo Figueroa presenting her work at NIH Postbac Poster Day 2024
Cecilia Monge, Safety Review Committee at National Cancer Institute, shared a post on LinkedIn: "NIH Postbac…
May 2, 2024, 15:29 |
Blog
Zainab Shinkafi-Bagudu: As we mark Immunization Week, let's give a nod to unsung heroes
Zainab Shinkafi-Bagudu shared on LinkedIn: "As we come to the end of Immunization Week, I'm reminded…
Apr 25, 2024, 11:47 |
Blog
Cecilia Monge B.: The Importance of Health Disparities in Liver Cancer in the Hispanic Population
Cecilia Monge B., Safety Review Committee at National Cancer Institute, shared a post on LinkedIn: "The Importance…
Apr 21, 2024, 18:27 |
Insight
Aradhana Kasimsetty: Denise Sabatino and I present a review of the known risks of AAV vector-mediated liver cancer
Aradhana Kasimsetty, Doctoral Candidate at the Perelman School of Medicine, shared on LinkedIn: “With the recent…
Apr 16, 2024, 20:44 |
Insight
Paper summary by Erman Akkus
Erman Akkus, Medical Oncology Fellow at Ankara University, shared on X/Twitter: "Incidence and mortality of…
Apr 13, 2024, 13:05 |
Insight
Amy Moore: Taking steps for cancer risk reduction
Amy Moore, VP of Global Engagement and Patient Partnerships at LUNGevity Foundation, shared a post…
Apr 11, 2024, 16:08 |
Insight
New Paper Alert! Exploring the Genomic Diversity of Cancer in Latin American Populations
Exploring the Genomic Diversity of Cancer in Latin American Populations Authors: Alejandro Ruíz-Patiño, Leonardo Rojas,…
Apr 10, 2024, 09:32 |
Insight
New Article Alert! New Findings on Personalized Vaccine and Pembrolizumab for Liver Cancer Treatment
New Findings on Personalized Vaccine and Pembrolizumab for Liver Cancer Treatment Authors: Mark Yarchoan, Edward…
Apr 5, 2024, 16:16 |
Blog
Sharlene Gill: Excited to be a faculty participant for the 14th Annual Asia-Pacific Primary Liver Cancer Expert Meeting
Sharlene Gill shared on LinkedIn: ''Excited to be a faculty participant for the 14th Annual Asia-Pacific…
Apr 5, 2024, 05:05 |
Blog
David Fajgenbaum: I had a PET scan to look into my Castleman disease, and the scan came back completely clear
David Fajgenbaum, Associate Professor of Medicine at University of Pennsylvania School of Medicine, shared a…
Feb 27, 2024, 05:27 |
Blog
Shubh Goel: Recently, I spoke to a Pharmaceutical Executive following data presented at ASCO GI from our EMERALD-1 and MATTERHORN Phase III trials
Shubh Goel, VP and US Franchise Head, Immuno-Oncology and GI Tumors at AstraZeneca, shared a…
Feb 8, 2024, 05:23 |
Blog
Khalis Mustafayev: Our recent article, co-authored with Dr. Vincent Mallet and Dr. Harrys Torres is now published in the Journal of Immunotherapy and Precision Oncology
Khalis Mustafayev, Postdoctoral FellowPostdoctoral Fellow at MD Anderson Cancer Center, recently shared on LinkedIn: "Exciting…
Jan 11, 2024, 07:19 |
History
Less Survivable Cancers Awareness Day
On January 11th each year, the United Kingdom recognizes Less Survivable Cancers Awareness Day, focusing…
Sep 29, 2023, 19:01 |
Insight
Pashtoon Kasi: N-of-1 Precision Medicine: This story is very dear to my heart.
Quoting Pashtoon Kasi, The Director of Colon Cancer Research at Weill Cornell Medicine, on X/Twitter: “N-of-1…
Aug 16, 2023, 19:43 |
Drugs
Arndt Vogel: FDA approves Melphalan as a liver-directed treatment for uveal melanoma.
Arndt Vogel, Head of the GI-Cancer Center and of the Center for Personalized Medicine at…
Aug 9, 2023, 21:00 |
Drugs
Atezolizumab/bevacizumab for the management of HCC in 1st setting - Arndt Vogel
🔥 off the press: Atezolizumab/bevacizumab for the management of HCC in 1st setting: systematic literature…
Jul 29, 2023, 19:39 |
Blog
By increasing hepatitis testing, we can save more lives - Todd Harper
Our Victorian Cancer Registry shows liver cancer is the sixth most common cause of cancer…
All:
26
Posts:
1 - 100
The largest philanthropic partnership in The V Foundation’s history - Dolphins Cancer Challenge
Glecirasib: A Promising Novel KRAS G12C Inhibitor in Clinical Development
How the Médecins Sans Frontières Journal Inspired a Lifetime of Humanitarian Service: Paul Spiegel
OncoDaily Party and Yvonne Award Photos - Part 1
Michael Douglas: The Untold Story of His Battle Against Cancer
Facebook
RSS Feed
Twitter
Linkedin
Youtube